Quince Therapeutics, Inc. QNCX Q4 2024 Annual earnings
Reported March 24, 2025 · Before market open
EPS estimate-$0.19
Next report
Aug 11, 2026 (in a month)EPS estimate-$25.40
Versus estimates
Diluted EPS
Ask the moment Quince Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Quince Therapeutics, Inc. report Q4 2024 earnings?
- Quince Therapeutics, Inc. (QNCX) reported Q4 2024 earnings on March 24, 2025 before market open.
- What were Quince Therapeutics, Inc.'s Q4 2024 revenue and EPS?
- Quince Therapeutics, Inc. reported diluted EPS of $-0.28 for Q4 2024.
- Did Quince Therapeutics, Inc. beat estimates in Q4 2024?
- EPS missed the consensus estimate of $-0.19 by $0.09.
- Where can I find Quince Therapeutics, Inc.'s Q4 2024 SEC filings?
- You can read the 10-K periodic report (0001662774-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.